- Home
- VOR vs GHI Comparison
VOR vs GHI Comparison
Compare VOR & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- GHI
- Stock Information
- Founded
- VOR 2015
- GHI 1998
- Country
- VOR United States
- GHI United States
- Employees
- VOR N/A
- GHI N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- VOR Health Care
- GHI Finance
- Exchange
- VOR Nasdaq
- GHI Nasdaq
- Market Cap
- VOR 261.2M
- GHI 269.5M
- IPO Year
- VOR 2021
- GHI N/A
- Fundamental
- Price
- VOR $1.99
- GHI $10.44
- Analyst Decision
- VOR Buy
- GHI Strong Buy
- Analyst Count
- VOR 7
- GHI 4
- Target Price
- VOR $3.77
- GHI $15.50
- AVG Volume (30 Days)
- VOR 4.9M
- GHI 51.9K
- Earning Date
- VOR 08-15-2025
- GHI 08-07-2025
- Dividend Yield
- VOR N/A
- GHI 14.26%
- EPS Growth
- VOR N/A
- GHI N/A
- EPS
- VOR N/A
- GHI N/A
- Revenue
- VOR N/A
- GHI $27,326,828.00
- Revenue This Year
- VOR N/A
- GHI $228.92
- Revenue Next Year
- VOR N/A
- GHI $4.27
- P/E Ratio
- VOR N/A
- GHI N/A
- Revenue Growth
- VOR N/A
- GHI N/A
- 52 Week Low
- VOR $0.13
- GHI $10.12
- 52 Week High
- VOR $3.29
- GHI $14.51
- Technical
- Relative Strength Index (RSI)
- VOR 51.36
- GHI 33.46
- Support Level
- VOR $2.02
- GHI $10.81
- Resistance Level
- VOR $2.14
- GHI $11.45
- Average True Range (ATR)
- VOR 0.19
- GHI 0.25
- MACD
- VOR -0.08
- GHI -0.05
- Stochastic Oscillator
- VOR 16.46
- GHI 22.31
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.